The expression levels of ERK1/2, NF-κB p65, and MMP2 in orthotopic tumors tissues. Orthotopic transplantation mice were randomly divided into 2 groups for treatment: intraperitoneal injection of EGb761 (40 mg/kg) or saline (0.9%) twice a week. Orthotopic tumors tissues were subjected to immunohistochemistry for ERK1/2, NF-κB p65, and MMP2. (A) The positive expression of ERK1/2, NF-κB p65, and MMP2 in the orthotopic tumors of control group and EGb761 group. Representative images are presented. (B) Positivity for ERK1/2, NF-κB p65, and MMP2 in cells in the EGb761 group and control group. N=5, mean ±SD, ** P<0.01 vs. control group. Scale bar: 50 μm.